Round 2 of Biointelect Venturer opening soon

Home › Resources › Round 2 of Biointelect Venturer opening soon

Read the full Round 2 media release here

Expressions of Interest for Round 2 of Biointelect Venturer will open on 21 September 2026, providing Australian SMEs, research teams and innovators with the opportunity to access funding and tailored support to advance technologies for the prevention of infectious diseases.

Biointelect Venturer is Australia’s national incubator for infectious disease innovation, supporting promising Australian technologies to accelerate their path from discovery to impact and progress towards commercial and investment readiness.

What Biointelect Venturer offers 

Successful applicants will have access to:

1. Catalytic non-dilutive funding

  • Non-dilutive, stage-gate funding to accelerate evidence generation, reduce development risk and progress projects towards key value-inflection points.

2. Tailored Development Support and Commercial Guidance

  • Project-specific strategic support and expert guidance across product development, regulatory and clinical pathways, CMC and manufacturing, intellectual property, commercialisation, market positioning, investment readiness and exit or partnering strategies.

3. Training and Capability Building

  • Practical workshops, masterclasses, mentoring designed to build each team’s capabilities across translation, product development, company building, regulatory strategy, commercialisation and investment readiness.

4. Network/facilitated access to partnerships and investors

  • Facilitated access to national and international experts, infrastructure, service providers, industry partners, funders and investors, as well as peer learning through the Biointelect Venturer community.

Biointelect Venturer is supported by the Australian Government through the Medical Research Future Fund (MRFF) 2024 BioMedTech Incubator Grant Opportunity.

EOIs open 21 September 2026, 9:00 AM AEST, and close 16 October 2026, 4:00 PM AEDT.

Access Round 2 Funding Guidelines here and FAQS here

Support for Round 2 Applications:

To support prospective Round 2 applicants, Biointelect Venturer will host an Information Session and a Grant Writing Workshop.

Information Session
Thursday 24 September 2026
11:00am – 12:00pm AEST

Learn more about Biointelect Venturer Round 2 eligibility and the application process, with an opportunity to ask questions.

Register for the Information Session

Grant Writing Workshop
Wednesday 30 September 2026
11:00am – 12:00pm AEST

A practical session designed to help prospective applicants understand the Round 2 application requirements and strengthen their EOI applications.

Register for the Grant Writing Workshop

Stay informed

Interested in Round 2? Join the Biointelect Venturer mailing list to receive program updates and important application information.

Related Resources

Want To Find Out More?

Are you interested in learning more about Biointelect, including our current white paper submissions and health policy related work?

Get in touch with our team to discover how we’re advancing healthcare for all and how you can harness our intellect and proven expertise in bringing innovative life science to market.

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.